Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

被引：0
|
作者：
Shubhadeep D. Sinha
Vamsi Krishna Bandi
Bala Reddy Bheemareddy
Pankaj Thakur
Sreenivasa Chary
Kalpana Mehta
Vikranth Reddy Pinnamareddy
Rajendra Pandey
Subhramanyam Sreepada
Santosh Durugkar
机构：
[1] Clinical Development and Medical Affairs,Department of Nephrology
[2] Hetero Group,Department of Nephrology
[3] Hetero Corporate,undefined
[4] B.L.Y Nair Hospital,undefined
[5] Care Hospitals,undefined
[6] Institute of Post Graduate Medical Education and Research Kolkata,undefined
[7] Sri Raghavendra Hospital,undefined
[8] Ashwini Hospital and Ramakanth Heart Care Center,undefined
来源：
BMC Nephrology | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.
引用
收藏
相关论文
共 50 条
  • [41] LIPOSOMIAL IRON FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN NON DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS: A RANDOMIZED CONTROLLED TRIAL
    Visciano, Bianca
    Nazzaro, Paola
    Riccio, Elenora
    Del Rio, Antonio
    Mozzillo, Giusi Rosaria
    Pisani, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 141 - 142
  • [42] Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis
    Park, Geo Neul
    Lee, Kyung Ho
    Moon, Ji Eun
    Choi, Soo Jeong
    Park, Moo Yong
    Kim, Jin Kuk
    Yu, Byung Chul
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2024, 43 (03) : 369 - 380
  • [43] Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study
    Fishbane, Steven
    Pollock, Carol A.
    El-Shahawy, Mohamed
    Escudero, Elizabeth T.
    Rastogi, Anjay
    Van, Bui Pham
    Frison, Lars
    Houser, Mark
    Pola, Maksym
    Little, Dustin J.
    Guzman, Nicolas
    Pergola, Pablo E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (04): : 850 - 866
  • [44] Letter to the Editor in response to the article "Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis"
    Farag, Youssef M. K.
    Zheng, Zihe
    Luo, Wenli
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [45] Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
    Tetsuhiro Tanaka
    Masaomi Nangaku
    Enyu Imai
    Yoshiharu Tsubakihara
    Masatoshi Kamai
    Michihito Wada
    Shinji Asada
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2019, 23 : 435 - 435
  • [46] An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
    Anna Wasilewska
    Rose Ann Murray
    Aimee Sundberg
    Sharif Uddin
    Heinrich Achenbach
    Aleksey Shavkin
    Tamás Szabó
    Andrea Vergani
    Obi Umeh
    BMC Nephrology, 23
  • [47] An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
    Wasilewska, Anna
    Murray, Rose Ann
    Sundberg, Aimee
    Uddin, Sharif
    Achenbach, Heinrich
    Shavkin, Aleksey
    Szabo, Tamas
    Vergani, Andrea
    Umeh, Obi
    BMC NEPHROLOGY, 2022, 23 (01)
  • [48] Correction to: Comparison of darbepoetin alpha and recombinant human erythropoietin for treatment of anemia in pediatric chronic kidney disease: a non-inferiority trial from India
    Rufaida Mazahir
    Kanav Anand
    P. K. Pruthi
    European Journal of Pediatrics, 2023, 182 : 111 - 112
  • [49] In response to "Title: Letter to the Editor in response to the article 'Efficacy and safety of HIF prolyl hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis"'
    Zheng, Qiyan
    Yang, Huisheng
    Liu, Yu Ning
    Liu, Wei Jing
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [50] POOLED EFFICACY AND CARDIOVASCULAR SAFETY RESULTS OF 3 PLACEBO-CONTROLLED AND 1 DARBEPOETIN ALFA-CONTROLLED STUDIES OF ROXADUSTAT FOR TREATMENT OF ANAEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE
    Barratt, Jonathan
    Dimkovic, Nada
    Shutov, Evgeny
    Sulowicz, Wladyslaw
    Esposito, Ciro
    Reusch, Michael
    Young, James
    Mariat, Christophe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345